RetinalGenix Technologies Inc.
RTGN · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | -100% | – |
| Cost of Goods Sold | $0 | $1 | $1 | $1 |
| Gross Profit | $0 | -$1 | -$1 | -$1 |
| % Margin | – | – | – | -879% |
| R&D Expenses | $20 | $14 | $13 | $104 |
| G&A Expenses | $270 | $384 | $341 | $392 |
| SG&A Expenses | $270 | $384 | $341 | $762 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $370 |
| Other Operating Expenses | $277 | $250 | $232 | -$1 |
| Operating Expenses | $568 | $648 | $586 | $865 |
| Operating Income | $0 | -$648 | -$586 | -$866 |
| % Margin | – | – | – | -866,067% |
| Other Income/Exp. Net | $0 | -$1 | -$1 | -$1 |
| Pre-Tax Income | -$569 | -$649 | -$587 | -$867 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$569 | -$649 | -$587 | -$867 |
| % Margin | – | – | – | -867,027% |
| EPS | -0.03 | -0.035 | -0.032 | -0.048 |
| % Growth | 15.3% | -11.7% | 34.4% | – |
| EPS Diluted | -0.03 | -0.035 | -0.032 | -0.048 |
| Weighted Avg Shares Out | 18,580 | 18,327 | 18,522 | 17,941 |
| Weighted Avg Shares Out Dil | 18,580 | 18,327 | 18,522 | 17,941 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $1 | $1 | $1 | $1 |
| Depreciation & Amortization | $1 | $1 | $1 | $1 |
| EBITDA | -$567 | -$648 | -$586 | -$865 |
| % Margin | – | – | – | -865,188% |